Literature DB >> 26335831

Comorbidities of asthma and the unified airway.

Robert J Stachler1,2.   

Abstract

BACKGROUND: Asthma is a comorbid condition that may be seen by otolaryngic allergists when treating their patients with allergic rhinitis (AR). Often asthma is overlooked when aggressive treatment could prevent the development or progression of early disease.
METHODS: This article is a retrospective review of the current literature on asthma as a comorbidity of the unified airway. The unified airway and asthma are clearly defined. The epidemiology, morbidity, mortality, pathophysiologic mechanisms, and the chronicity of asthma are reviewed.
RESULTS: The otolaryngic allergist will become familiar the unified airway concept and the close relationships between AR, chronic rhinosinusitis, and asthma.
CONCLUSION: Otolaryngologists should be aware of the unified airway in order to most effectively treat their patients with AR. Knowledge of the close relationships between asthma and AR will help prevent progression of disease, identify early asthma, and improve the outcomes and quality of life for our patients.
© 2015 ARS-AAOA, LLC.

Entities:  

Keywords:  allergic rhinitis; allergy; asthma; chronic rhinosinusitis; rhinitis; unified airway

Mesh:

Year:  2015        PMID: 26335831     DOI: 10.1002/alr.21615

Source DB:  PubMed          Journal:  Int Forum Allergy Rhinol        ISSN: 2042-6976            Impact factor:   3.858


  11 in total

1.  FeNO for detecting lower airway involvement in patients with allergic rhinitis.

Authors:  Zheng Zhu; Yanqing Xie; Weijie Guan; Yi Gao; Shu Xia; Nanshan Zhong; Jinping Zheng
Journal:  Exp Ther Med       Date:  2016-08-23       Impact factor: 2.447

2.  Does chronic rhinosinusitis relate to systemic hypoxemia?

Authors:  Neil Bhattacharyya
Journal:  Laryngoscope Investig Otolaryngol       Date:  2020-09-30

Review 3.  Sinuses and Common Rhinologic Conditions.

Authors:  Nyall R London; Murugappan Ramanathan
Journal:  Med Clin North Am       Date:  2018-08-18       Impact factor: 5.456

Review 4.  Guidelines for the Antibiotic Use in Adults with Acute Upper Respiratory Tract Infections.

Authors:  Young Kyung Yoon; Chan Soon Park; Jae Wook Kim; Kyurin Hwang; Sei Young Lee; Tae Hoon Kim; Do Yang Park; Hyun Jun Kim; Dong Young Kim; Hyun Jong Lee; Hyun Young Shin; Yong Kyu You; Dong Ah Park; Shin Woo Kim
Journal:  Infect Chemother       Date:  2017-12

5.  Autonomic nervous system dysfunction and sinonasal symptoms.

Authors:  Alexander Yao; Janet A Wilson; Stephen L Ball
Journal:  Allergy Rhinol (Providence)       Date:  2018-04-16

6.  Asthma increases the risk of herpes zoster: a nested case-control study using a national sample cohort.

Authors:  So Young Kim; Dong Jun Oh; Hyo Geun Choi
Journal:  Allergy Asthma Clin Immunol       Date:  2020-06-23       Impact factor: 3.406

7.  Association of chronic rhinosinusitis with bronchial asthma and its severity: A protocol for systematic review and meta-analysis.

Authors:  Yangwang Pan; Hongrui Zang
Journal:  Medicine (Baltimore)       Date:  2021-03-05       Impact factor: 1.817

8.  The GSDMB rs7216389 SNP is associated with chronic rhinosinusitis in a multi-institutional cohort.

Authors:  Dana E Zack; Debra A Stern; Amanda L Willis; Alexander S Kim; Corinne J Mansfield; Danielle R Reed; Steven G Brooks; Nithin D Adappa; James N Palmer; Noam A Cohen; Alexander G Chiu; Brian H Song; Chris H Le; Eugene H Chang
Journal:  Int Forum Allergy Rhinol       Date:  2021-06-02       Impact factor: 3.858

Review 9.  Prevalence of Comorbidities in Asthma and Nonasthma Patients: A Meta-analysis.

Authors:  Xinming Su; Yuan Ren; Menglu Li; Xuan Zhao; Lingfei Kong; Jian Kang
Journal:  Medicine (Baltimore)       Date:  2016-05       Impact factor: 1.889

10.  Increased nasal matrix metalloproteinase-1 and -9 expression in smokers with chronic rhinosinusitis and asthma.

Authors:  Chien-Chia Huang; Chun-Hua Wang; Pei-Wen Wu; Jung-Ru He; Chi-Che Huang; Po-Hung Chang; Chia-Hsiang Fu; Ta-Jen Lee
Journal:  Sci Rep       Date:  2019-10-25       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.